Weave Communications, Inc. (WEAV)

NYSE: WEAV · Real-Time Price · USD

7.29

-0.01 (-0.14%)

At close: Aug 28, 2026, 4:00 PM EDT

7.30

+0.01 (0.14%)

After-hours: Aug 28, 2026, 7:30 PM EDT

-0.14% (1D)

Market Cap	583.19M -2.3%
Revenue (ttm)	257.79M +16.7%
Net Income	-20.54M
EPS	-0.26
Shares Out	80.00M
PE Ratio	n/a
Forward PE	36.91
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,048,224
Open	7.30
Previous Close	7.30
Day's Range	7.29 - 7.31
52-Week Range	4.24 - 8.00
Beta	1.67
Analysts	Hold
Price Target	7.40 (+1.51%)
Earnings Date	Aug 6, 2026

About WEAV

Weave Communications, Inc. operates an AI-powered patient communications, engagement, and payments platform for small and medium-sized healthcare businesses. It offers AI-receptionist; Unified Phone Number; Customized Phone System, a smarter phone system to identify whether incoming calls are from new or current patients, provide information at every call, and manage heavy call times; Softphones to make and receive calls from anywhere with an internet connection; Text Messaging and SMS response assistant; Missed Call Text that allows practices ... [Read more]

Industry Health Information Services

Sector Healthcare

IPO Date Nov 11, 2021

Employees 904

Stock Exchange NYSE

Ticker Symbol WEAV

Website https://www.getweave.com

Full Company Profile

Financial Performance

In 2025, Weave Communications's revenue was $239.02 million, an increase of 16.99% compared to the previous year's $204.31 million. Losses were -$28.05 million, -1.04% less than in 2024.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for WEAV stock is "Hold." The 12-month stock price target is $7.4, which is an increase of 1.51% from the latest price.

Price Target

$7.4

(1.51% upside)

Analyst Consensus: Hold

Stock Forecasts

News

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH)

BALA CYNWYD, Pa., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (j...

Other symbols: FULC IRDM TECH

5 days ago - GlobeNewsWire

Weave downgraded to Market Perform from Outperform at Raymond James

Raymond James downgraded Weave (WEAV) to Market Perform from Outperform without a price target after the company entered into an agreement to be acquired by Francisco Partners for $650M or…

6 days ago - TheFly

Weave's 2026 Pulse Survey Finds Healthcare Practices Are Ready for AI, but 60% Are Still Concerned About Data Privacy

LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, today released its 2026 State of Heal...

9 days ago - Business Wire

Halper Sadeh LLC is Investigating Whether WEAV and FULC are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

Other symbols: FULC

10 days ago - GlobeNewsWire

Weave downgraded to Neutral from Buy at B. Riley

B. Riley downgraded Weave (WEAV) to Neutral from Buy with a price target of $7.40, down from $8.25, after the company entered into an agreement to be acquired by Francisco…

10 days ago - TheFly

Weave Communications Proxy statement: Proxy filing

Weave Communications filed a proxy statement on August 19, 2026, providing details for shareholder voting and corporate governance matters.

10 days ago - Filings

Weave downgraded to Hold from Buy at Loop Capital

Loop Capital analyst Mark Schappel downgraded Weave (WEAV) to Hold from Buy with a price target of $7.40, down from $8, after the company entered into an agreement to be…

11 days ago - TheFly

Weave downgraded to Neutral from Overweight at Piper Sandler

Piper Sandler analyst Hannah Rudoff downgraded Weave (WEAV) to Neutral from Overweight with a price target of $7.40, down from $8, after the company entered into an agreement to be…

11 days ago - TheFly

Weave downgraded to Hold from Buy at Stifel

Stifel downgraded Weave (WEAV) to Hold from Buy with a price target of $7.40, down from $8, after the company entered into an agreement to be acquired by Francisco Partners…

11 days ago - TheFly

Weave Communications trading resumes

09:11 EDT Weave (WEAV) Communications trading resumes

11 days ago - TheFly

Francisco Partners to acquire Weave for $7.40 per share in cash

Weave (WEAV) Communications and Francisco Partners announced that FP has entered into a definitive agreement to acquire Weave, at an aggregate equity valuation of approximately $650M. Under the terms ...

11 days ago - TheFly

Weave initiated with a Buy at B. Riley

B. Riley analyst Josh Nichols initiated coverage of Weave (WEAV) with a Buy rating and $8.25 price target Weave offers an attractive risk/reward profile, with durable 13%-15% growth, improving margins...

11 days ago - TheFly

Weave Announces Acquisition by Francisco Partners

LEHI, Utah & SAN FRANCISCO--(BUSINESS WIRE)-- #getweave--Weave Communications, Inc. (“Weave”) (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare p...

11 days ago - Business Wire

Weave Communications trading halted, news pending

08:44 EDT Weave (WEAV) Communications trading halted, news pending

11 days ago - TheFly